Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)

Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data

NCT05313854 ·Status: UNKNOWN

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

NCT00149578 ·Status: UNKNOWN ·Phase: PHASE2

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

NCT06582342 ·Status: RECRUITING

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

NCT02496832 ·Status: WITHDRAWN ·Phase: NA

Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study

NCT01995240 ·Status: COMPLETED ·Phase: NA

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

NCT06305728 ·Status: RECRUITING

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07217717 ·Status: RECRUITING ·Phase: PHASE3

Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas

NCT02205788 ·Status: WITHDRAWN

Feasibility Study of LUM Imaging System for Pancreatic Cancer

NCT04276909 ·Status: WITHDRAWN ·Phase: NA

INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors

NCT04436679 ·Status: COMPLETED

The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan

NCT02296736 ·Status: COMPLETED

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

NCT04975516 ·Status: TERMINATED ·Phase: PHASE2

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

NCT05298722 ·Status: RECRUITING ·Phase: NA

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

NCT03726021 ·Status: COMPLETED ·Phase: PHASE2

Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection

NCT02750657 ·Status: COMPLETED

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

NCT01972919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

NCT06144762 ·Status: RECRUITING ·Phase: NA

Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma

NCT01474564 ·Status: COMPLETED

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

NCT05262855 ·Status: COMPLETED ·Phase: PHASE2

Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma

NCT04565327 ·Status: TERMINATED ·Phase: PHASE2

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

NCT07117045 ·Status: RECRUITING

Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC

NCT03032913 ·Status: COMPLETED

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

NCT02459652 ·Status: COMPLETED ·Phase: PHASE2

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

NCT06600906 ·Status: RECRUITING

Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer

NCT04954378 ·Status: COMPLETED